Clinical correlates of mitochondrial function in Huntington's disease muscle
Christopher Turner1, J Mark Cooper, Anthony H V Schapira
1University Department of Clinical Neurosciences, Royal Free and University College Medical School, University College London, London, United Kingdom.
Insights
Huntington's disease (HD) involves CAG repeat expansion affecting huntingtin protein. This study found that mitochondrial complex II/III function in skeletal muscle correlates with HD progression and clinical symptoms, suggesting muscle as a potential disease marker.
Area of Science:
- Neuroscience
- Genetics
- Mitochondrial Biology
Background:
- Huntington's disease (HD) is a neurodegenerative disorder caused by CAG repeat expansion in the IT-15 gene, leading to mutant huntingtin protein.
- Mitochondrial dysfunction and energy metabolism defects are implicated in HD, observed in both brain and skeletal muscle tissues.
Purpose of the Study:
- To investigate mitochondrial respiratory chain function in skeletal muscle of HD patients.
- To correlate muscle mitochondrial function with clinical parameters and disease progression in HD.
Main Methods:
- Histochemical and biochemical analyses of mitochondrial respiratory chain complexes (I-IV) in skeletal muscle from 12 HD patients and 12 controls.
- Correlation of enzyme activities with clinical data, including the Unified Huntington's Disease Rating Scale (UHDRS), disease duration, and CAG repeat years.
Main Results:
- No significant differences in activities of mitochondrial complexes I-IV between HD patients and controls.
- Significant correlations found between mitochondrial complex II/III activities and HD disease duration, CAG repeat years, and cognitive scores.
- Ultrastructural evidence suggested inclusion body formation in HD muscle tissue.
Conclusions:
- Mutant huntingtin protein impacts mitochondrial complex II/III function in skeletal muscle, a non-neuronal tissue.
- Skeletal muscle mitochondrial function, particularly complex II/III, may serve as a potential biomarker for Huntington's disease progression.
Abstract:
Huntington's disease (HD) is caused by an abnormally expanded CAG repeat in the IT-15 gene, which encodes a widely expressed protein called huntingtin. Abnormalities of mitochondrial respiratory chain function, specifically complex II/III, have been identified in HD striatum and defects of energy metabolism have been demonstrated in vivo in skeletal muscle in both symptomatic and presymptomatic HD patients. We have investigated respiratory chain function using histochemical and biochemical methods in HD skeletal muscle from 12 patients and compared these with 12 age and sex-matched controls. The data from the HD patients were related to clinical parameters of HD including the Unified Huntington's Disease Rating Scale (UHDRS). There were positive correlations between CAG repeat years (a product of CAG repeat length and age) and both motor (P < 0.002) and cognitive (P < 0.01) scores of the UHDRS. There was no significant difference in the activities of complexes I to IV compared to age-matched controls. However, there were significant correlations for individual HD complex II/III activities with disease duration (P = 0.017), repeat years (P = 0.032), and cognitive scores (P = 0.019). There was also evidence from ultrastructural studies that inclusion formation may occur in HD muscle. These results provide additional evidence that mutant huntingtin influences mitochondrial complex II/III function in non-neuronal tissue (skeletal muscle) and suggest that muscle may be a potential marker of disease progression in HD.
Related Concept Videos
Huntington Disease l: Introduction
Alterations in Muscle Tone lll
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Animal Mitochondrial Genetics


